Over the past few decades, food contamination caused by antibiotic residues has emerged as a global issue mainly caused by the improper usage of antibiotics. At present, the development of easy, high-throughput, cost-effective, and rapid screening techniques for the detection of antibiotic residues has gained considerable momentum due to the increasing need to find alternatives for conventional assays– a factor that is expected to boost the growth of the global multiplex detection immunoassays market during the forecast period. Moreover, immunoassays are gaining popularity as a promising evaluation technique for environmental and food protection. This is likely to accelerate innovations across the global multiplex detection immunoassays market.
At present, a number of players involved in the current global multiplex detection immunoassays market landscape is increasingly focusing on the development of different types of multiplex detection immunoassays such as radioimmunoassay, colloidal gold immunoassay, enzyme-linked immunoassay, and chemiluminescence immunoassays among others to swiftly detect antibiotic residues. Market players are projected to focus on improving the performance of multiplex detection immunoassays to establish a solid foothold in the competitive landscape. The demand for screening of antibiotic residues is anticipated to witness a considerable spike, particularly in the first half of the forecast due to the outbreak of the COVID-19 pandemic. This is likely to aid the growth of the global multiplex detection immunoassays market.
At the back of these factors, along with a surge in the number of research and development activities, the global multiplex detection immunoassays market is on the course to surpass US$ 3.65 Bn mark by the end of 2030.
Multiplex detection immunoassays are increasingly being used in a wide range of applications, including infectious disease testing, food contamination testing, veterinary disease testing, and R&D activities. The increasing demand for multiplex detection immunoassays for clinical diagnosis is expected to accelerate the development of multiplex detection immunoassays in the upcoming years– a factor that is set to fuel the growth of the market for global multiplex detection immunoassays during the assessment period. Prosthetic joint replacements are primarily used to enhance the quality of life, restore the joint function, and improve mobility. Although prosthetic joint replacement is a globally accepted treatment, prosthetic joint infection is one of the major causes of knee arthroplasties, which makes early diagnosis critical. This is set to drive the demand for multiplex detection immunoassays.
As a measure to prevent prosthetic joint infection, a number of immunoassays are available to assist in the early detection of infections out of which, lateral flow multiplex detection immunoassay is at the forefront in terms of adoption due to the low-costs, speed, and simplicity.
The noteworthy surge in the demand for point of care diagnostic devices for rapid initial screening in various non-laboratory setting is another factor that is anticipated to provide a considerable boost to the growth of the global multiplex detection immunoassays market during the assessment period. The demand for ‘near-patient tests’ is on the rise, owing to its high patient convenience. Some of the most widely used point-of-care tests include blood glucose tests, drug screenings, and food pathogens. At present, a range of point-of-care immunoassays is available to determine the presence of various pathogens and substances, and efforts are being made to improve the quality and performance of the same, thus driving the multiplex detection immunoassays market during the assessment period.
The outbreak of the COVID-19 pandemic is projected to have a strong impact on the growth of the global multiplex detection immunoassays market. Research and development activities are expected to gain considerable traction across the global multiplex detection immunoassays market during the ongoing COVID-19 health crisis. At present, scientists and researchers are increasingly focusing on the development of multiplex serologic assays to enable swift detection and surveillance of known human coronaviruses. Research and development activities are anticipated to set the tone for the growth of the global multiplex detection immunoassays market in the upcoming years.
Analysts’ Viewpoint
The global multiplex detection immunoassays market is anticipated to grow at a healthy CAGR of 7.5% during the forecast period. The market growth is primarily driven by a host of factors, including increasing need for swift and early detection of antibiotic residues for food and environmental protection, significant rise in the prevalence of infectious and chronic diseases, and increase in emphasis on research and development. The outbreak of the COVID-19 pandemic will play a key role in accelerating research and development activities, as researchers and scientists continue to leverage multiplex detection immunoassays for the detection of human coronaviruses worldwide.
Multiplex detection immunoassays market to surpass valuation of US$ 3.65 Bn by 2030
Multiplex detection immunoassays market is projected to expand at a CAGR of 7.5% from 2020 to 2030
Multiplex detection immunoassays market is driven by increase in incidence rate of chronic and infectious diseases
North America accounted for major share of the global multiplex detection immunoassays market
Key players in the global multiplex detection immunoassays market include Hoffmann-La Roche Ltd., QIAGEN, Merck KGaA, Microsynth AG, Bio-Rad Laboratories
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Multiplex Detection Immunoassays Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Multiplex Detection Immunoassays Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Technological Advancement
5.2. Key Mergers & Acquisitions
5.3. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)
6. Global Multiplex Detection Immunoassays Market Analysis and Forecast, by Assay Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Assay Type, 2018–2030
6.3.1. Planar Assays
6.3.1.1. Blends Protein Arrays (multiplexed ELISA)
6.3.1.2. Antibody Arrays
6.3.2. Bead-based Assays
6.3.2.1. Magnetic Bead-based
6.3.2.2. Non-magnetic Bead-based
6.4. Market Attractiveness Analysis, by Assay Type
7. Global Multiplex Detection Immunoassays Market Analysis and Forecasts, by Technique
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Technique, 2018–2030
7.3.1. Nucleic Acid-based Techniques
7.3.2. Protein-based Techniques
7.3.3. Biosensor-based Techniques
7.4. Market Attractiveness Analysis, by Technique
8. Global Multiplex Detection Immunoassays Market Analysis and Forecast, by Application
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Application, 2018–2030
8.3.1. Disease Testing
8.3.1.1. Infectious Disease Testing
8.3.1.2. Autoimmune Disease Testing
8.3.1.3. Other Diseases Testing
8.3.2. Food Contamination Testing
8.3.3. Research & Development
8.3.4. Veterinary Disease Testing
8.4. Market Attractiveness Analysis, by Application
9. Global Multiplex Detection Immunoassays Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2018–2030
9.3.1. Pharmaceutical & Biopharmaceutical Companies
9.3.2. Clinical Research Organizations
9.3.3. Food & Beverage Industry
9.3.4. Academic & Research Institutes
9.3.5. Diagnostic Centers
9.3.6. Others
9.4. Market Attractiveness Analysis, by End-user
10. Global Multiplex Detection Immunoassays Market Analysis and Forecasts, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Country/Region
11. North America Multiplex Detection Immunoassays Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Assay Type, 2018–2030
11.2.1. Planar Assays
11.2.1.1. Blends Protein Arrays (multiplexed ELISA)
11.2.1.2. Antibody Arrays
11.2.2. Bead-based Assays
11.2.2.1. Magnetic Bead-based
11.2.2.2. Non-magnetic Bead-based
11.3. Market Value Forecast, by Technique, 2018–2030
11.3.1. Nucleic Acid-based Techniques
11.3.2. Protein-based Techniques
11.3.3. Biosensor-based Techniques
11.4. Market Value Forecast, by Application, 2018–2030
11.4.1. Disease Testing
11.4.1.1. Infectious Disease Testing
11.4.1.2. Autoimmune Disease Testing
11.4.1.3. Other Diseases Testing
11.4.2. Food Contamination Testing
11.4.3. Research & Development
11.4.4. Veterinary Disease Testing
11.5. Market Value Forecast, by End-user, 2018–2030
11.5.1. Pharmaceutical & Biopharmaceutical Companies
11.5.2. Clinical Research Organizations
11.5.3. Food & Beverage Industry
11.5.4. Academic & Research Institutes
11.5.5. Diagnostic Centers
11.5.6. Others
11.6. Market Value Forecast, by Country, 2018–2030
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Assay Type
11.7.2. By Technique
11.7.3. By Application
11.7.4. By End-user
11.7.5. By Country
12. Europe Multiplex Detection Immunoassays Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Assay Type, 2018–2030
12.2.1. Planar Assays
12.2.1.1. Blends Protein Arrays (multiplexed ELISA)
12.2.1.2. Antibody Arrays
12.2.2. Bead-based Assays
12.2.2.1. Magnetic Bead-based
12.2.2.2. Non-magnetic Bead-based
12.3. Market Value Forecast, by Technique, 2018–2030
12.3.1. Nucleic Acid-based Techniques
12.3.2. Protein-based Techniques
12.3.3. Biosensor-based Techniques
12.4. Market Value Forecast, by Application, 2018–2030
12.4.1. Disease Testing
12.4.1.1. Infectious Disease Testing
12.4.1.2. Autoimmune Disease Testing
12.4.1.3. Other Diseases Testing
12.4.2. Food Contamination Testing
12.4.3. Research & Development
12.4.4. Veterinary Disease Testing
12.5. Market Value Forecast, by End-user, 2018–2030
12.5.1. Pharmaceutical & Biopharmaceutical Companies
12.5.2. Clinical Research Organizations
12.5.3. Food & Beverage Industry
12.5.4. Academic & Research Institutes
12.5.5. Diagnostic Centers
12.5.6. Others
12.6. Market Value Forecast, by Country/Sub-region, 2018–2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Assay Type
12.7.2. By Technique
12.7.3. By Application
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Multiplex Detection Immunoassays Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Assay Type, 2018–2030
13.2.1. Planar Assays
13.2.1.1. Blends Protein Arrays (multiplexed ELISA)
13.2.1.2. Antibody Arrays
13.2.2. Bead-based Assays
13.2.2.1. Magnetic Bead-based
13.2.2.2. Non-magnetic Bead-based
13.3. Market Value Forecast, by Technique, 2018–2030
13.3.1. Nucleic Acid-based Techniques
13.3.2. Protein-based Techniques
13.3.3. Biosensor-based Techniques
13.4. Market Value Forecast By Application, 2018–2030
13.4.1. Disease Testing
13.4.1.1. Infectious Disease Testing
13.4.1.2. Autoimmune Disease Testing
13.4.1.3. Other Diseases Testing
13.4.2. Food Contamination Testing
13.4.3. Research & Development
13.4.4. Veterinary Disease Testing
13.5. Market Value Forecast, by End-user, 2018–2030
13.5.1. Pharmaceutical & Biopharmaceutical Companies
13.5.2. Clinical Research Organizations
13.5.3. Food & Beverage Industry
13.5.4. Academic & Research Institutes
13.5.5. Diagnostic Centers
13.5.6. Others
13.6. Market Value Forecast, by Country/Sub-region, 2018–2030
13.6.1. China
13.6.2. India
13.6.3. Japan
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia pacific
13.7. Market Attractiveness Analysis
13.7.1. By Assay Type
13.7.2. By Technique
13.7.3. By Application
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Multiplex Detection Immunoassays Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Assay Type, 2018–2030
14.2.1. Planar Assays
14.2.1.1. Blends Protein Arrays (multiplexed ELISA)
14.2.1.2. Antibody Arrays
14.2.2. Bead-based Assays
14.2.2.1. Magnetic Bead-based
14.2.2.2. Non-magnetic Bead-based
14.3. Market Value Forecast, by Technique, 2018–2030
14.3.1. Nucleic Acid-based Techniques
14.3.2. Protein-based Techniques
14.3.3. Biosensor-based Techniques
14.4. Market Value Forecast, by Application, 2018–2030
14.4.1. Disease Testing
14.4.1.1. Infectious Disease Testing
14.4.1.2. Autoimmune Disease Testing
14.4.1.3. Other Diseases Testing
14.4.2. Food Contamination Testing
14.4.3. Research & Development
14.4.4. Veterinary Disease Testing
14.5. Market Value Forecast, by End-user, 2018–2030
14.5.1. Pharmaceutical & Biopharmaceutical Companies
14.5.2. Clinical Research Organizations
14.5.3. Food & Beverage Industry
14.5.4. Academic & Research Institutes
14.5.5. Diagnostic Centers
14.5.6. Others
14.6. Market Value Forecast, by Country/Sub-region, 2018–2030
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Assay Type
14.7.2. By Technique
14.7.3. By Application
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Multiplex Detection Immunoassays Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Assay Type, 2018–2030
15.2.1. Planar Assays
15.2.1.1. Blends Protein Arrays (multiplexed ELISA)
15.2.1.2. Antibody Arrays
15.2.2. Bead-based Assays
15.2.2.1. Magnetic Bead-based
15.2.2.2. Non-magnetic Bead-based
15.3. Market Value Forecast, by Technique, 2018–2030
15.3.1. Nucleic Acid-based Techniques
15.3.2. Protein-based Techniques
15.3.3. Biosensor-based Techniques
15.4. Market Value Forecast, by Application, 2018–2030
15.4.1. Disease Testing
15.4.1.1. Infectious Disease Testing
15.4.1.2. Autoimmune Disease Testing
15.4.1.3. Other Diseases Testing
15.4.2. Food Contamination Testing
15.4.3. Research & Development
15.4.4. Veterinary Disease Testing
15.5. Market Value Forecast, by End-user, 2018–2030
15.5.1. Pharmaceutical & Biopharmaceutical Companies
15.5.2. Clinical Research Organizations
15.5.3. Food & Beverage Industry
15.5.4. Academic & Research Institutes
15.5.5. Diagnostic Centers
15.5.6. Others
15.6. Market Value Forecast, by Country/Sub-region, 2018–2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Assay Type
15.7.2. By Technique
15.7.3. By Application
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company, 2018
16.3. Company Profiles
16.3.1. F. Hoffmann-La Roche Ltd.
16.3.1.1. Company Overview
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. QIAGEN
16.3.2.1. Company Overview
16.3.2.2. Company Financials
16.3.2.3. Growth Strategies
16.3.2.4. SWOT Analysis
16.3.3. Merck KGaA
16.3.3.1. Company Overview
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. Microsynth AG
16.3.4.1. Company Overview
16.3.4.2. Company Financials
16.3.4.3. Growth Strategies
16.3.4.4. SWOT Analysis
16.3.5. Bio-Rad Laboratories
16.3.5.1. Company Overview
16.3.5.2. Company Financials
16.3.5.3. Growth Strategies
16.3.5.4. SWOT Analysis
16.3.6. Thermo Fisher Scientific
16.3.6.1. Company Overview
16.3.6.2. Company Financials
16.3.6.3. Growth Strategies
16.3.6.4. SWOT Analysis
16.3.7. Luminex Corporation
16.3.7.1. Company Overview
16.3.7.2. Company Financials
16.3.7.3. Growth Strategies
16.3.7.4. SWOT Analysis
16.3.8. Becton, Dickinson and Company
16.3.8.1. Company Overview
16.3.8.2. Company Financials
16.3.8.3. Growth Strategies
16.3.8.4. SWOT Analysis
16.3.9. Other Prominent Key Players
List of Tables
Table 01: Global Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Assay Type, 2018–2030
Table 02: Global Multiplex Detection Immunoassays Market Volume (Thousand Units) Forecast, by Planar Assays, 2018–2030
Table 03: Global Multiplex Detection Immunoassays Market Volume (Thousand Units) Forecast, by Bead-based Assays, 2018–2030
Table 04: Global Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Technique, 2018–2030
Table 05: Global Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 06: Global Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Disease Testing, 2018–2030
Table 07: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn) Forecast, by End-user, 2018–2030
Table 08: Global Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 09: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 10: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Assay Type, 2018–2030
Table 11: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Planar Assays, 2018–2030
Table 12: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Bead-based Assays, 2018–2030
Table 13: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Technique, 2018–2030
Table 14: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 15: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Disease Testing, 2018–2030
Table 16: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 17: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 18: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Assay Type, 2018–2030
Table 19: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Planar Assays, 2018–2030
Table 20: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Bead-based Assays, 2018–2030
Table 21: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Technique, 2018–2030
Table 22: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 23: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Disease Testing, 2018–2030
Table 24: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 25: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 26: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Assay Type, 2018–2030
Table 27: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Planar Assays, 2018–2030
Table 28: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Bead-based Assays, 2018–2030
Table 29: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Technique, 2018–2030
Table 30: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 31: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Disease Testing, 2018–2030
Table 32: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 33: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 34: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Assay Type, 2018–2030
Table 35: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Planar Assays, 2018–2030
Table 36: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Bead-based Assays, 2018–2030
Table 37: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Technique, 2018–2030
Table 38: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 39: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Disease Testing, 2018–2030
Table 40: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 41: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 42: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Assay Type, 2018–2030
Table 43: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Planar Assays, 2018–2030
Table 44: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Bead-based Assays, 2018–2030
Table 45: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Technique, 2018–2030
Table 46: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Application, 2018–2030
Table 47: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by Disease Testing, 2018–2030
Table 48: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, by End-user, 2018–2030
List of Figures
Figure 01: Global Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Multiplex Detection Immunoassays Market Value Share, by Technique, 2019
Figure 03: Global Multiplex Detection Immunoassays Market Value Share, by Application, 2019
Figure 04: Global Multiplex Detection Immunoassays Market Value Share, by Assay Type, 2019
Figure 05: Global Multiplex Detection Immunoassays Market Value Share, by End-user, 2019
Figure 06: Global Multiplex Detection Immunoassays Market Value Share Analysis, by Type, 2019 and 2030
Figure 07: Global Multiplex Detection Immunoassays Market Attractiveness Analysis, by Type, 2020–2030
Figure 08: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Planar Assays, 2018–2030
Figure 09: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Bead-based Assays, 2018–2030
Figure 10: Global Multiplex Detection Immunoassays Market Value Share Analysis, by Technique, 2019 and 2030
Figure 11: Global Multiplex Detection Immunoassays Market Attractiveness Analysis, by Technique, 2020–2030
Figure 12: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Nucleic Acid-based Techniques, 2018–2030
Figure 13: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Protein-based Techniques, 2018–2030
Figure 14: Global Multiplex Detection Immunoassays Mar Revenue (US$ Mn), by Biosensor-based Techniques, 2018–2030
Figure 15: Global Multiplex Detection Immunoassays Market Value Share Analysis, by Application, 2019 and 2030
Figure 16: Global Multiplex Detection Immunoassays Market Attractiveness Analysis, by Application, 2020–2030
Figure 17: Global Multiplex Detection Immunoassays Market Value (US$ Mn), by Disease Testing, 2018–2030
Figure 18: Global Multiplex Detection Immunoassays Market Value (US$ Mn), by Food Contamination Testing, 2018–2030
Figure 19: Global Multiplex Detection Immunoassays Market Value (US$ Mn), by Research & Development, 2018–2030
Figure 20: Global Multiplex Detection Immunoassays Market Value (US$ Mn), by Veterinary Disease Testing, 2018–2030
Figure 21: Global Multiplex Detection Immunoassays Market Value Share Analysis, by End-user, 2019 and 2030
Figure 22: Global Multiplex Detection Immunoassays Market Attractiveness Analysis, by End-user, 2020–2030
Figure 23: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Pharmaceutical & Biopharmaceutical Companies, 2018–2030
Figure 24: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Clinical Research Organizations, 2018–2030
Figure 25: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Food & Beverage Industry, 2018–2030
Figure 26: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Academic & Research Institutes, 2018–2030
Figure 27: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Diagnostic Centers, 2018–2030
Figure 28: Global Multiplex Detection Immunoassays Market Revenue (US$ Mn), by Others, 2018–2030
Figure 29: Global Multiplex Detection Immunoassays Market Value Share Analysis, by Region, 2019 and 2030
Figure 30: Global Multiplex Detection Immunoassays Market Attractiveness Analysis, by Region, 2020–2030
Figure 31: North America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 32: North America Multiplex Detection Immunoassays Market Value Share, by Country, 2019–2030
Figure 33: North America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Country, 2019–2030
Figure 34: North America Multiplex Detection Immunoassays Market Value Share Analysis, by Assay Type, 2019 and 2030
Figure 35: North America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Assay Type, 2020–2030
Figure 36: North America Multiplex Detection Immunoassays Market Value Share Analysis, by Technique, 2019 and 2030
Figure 37: North America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Technique, 2020–2030
Figure 38: North America Multiplex Detection Immunoassays Market Value Share (%), by Application, 2019 and 2030
Figure 39: North America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Application, 2020–2030
Figure 40: North America Multiplex Detection Immunoassays Market Value Share (%), by End-user, 2019 and 2030
Figure 41: North America Multiplex Detection Immunoassays Market Attractiveness Analysis, by End-user, 2020–2030
Figure 42: Europe Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 43: Europe Multiplex Detection Immunoassays Market Value Share, by Country/Sub-region, 2019–2030
Figure 44: Europe Multiplex Detection Immunoassays Market Attractiveness Analysis, by Country/Sub-region, 2019–2030
Figure 45: Europe Multiplex Detection Immunoassays Market Value Share Analysis, by Assay Type, 2019 and 2030
Figure 46: Europe Multiplex Detection Immunoassays Market Attractiveness Analysis, by Assay Type, 2020–2030
Figure 47: Europe Multiplex Detection Immunoassays Market Value Share Analysis, by Technique, 2019 and 2030
Figure 48: Europe Multiplex Detection Immunoassays Market Attractiveness Analysis, by Technique, 2020–2030
Figure 49: Europe Multiplex Detection Immunoassays Market Value Share (%), by Application, 2019 and 2030
Figure 50: Europe Multiplex Detection Immunoassays Market Attractiveness Analysis, by Application, 2020–2030
Figure 51: Europe Multiplex Detection Immunoassays Market Value Share (%), by End-user, 2019 and 2030
Figure 52: Europe Multiplex Detection Immunoassays Market Attractiveness Analysis, by End-user, 2020–2030
Figure 53: Asia Pacific Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 54: Asia Pacific Multiplex Detection Immunoassays Market Value Share, by Country/Sub-region, 2019–2030
Figure 55: Asia Pacific Multiplex Detection Immunoassays Market Attractiveness Analysis, by Country/Sub-region, 2019–2030
Figure 56: Asia Pacific Multiplex Detection Immunoassays Market Value Share Analysis, by Assay Type, 2019 and 2030
Figure 57: Asia Pacific Multiplex Detection Immunoassays Market Attractiveness Analysis, by Assay Type, 2020–2030
Figure 58: Asia Pacific Multiplex Detection Immunoassays Market Value Share Analysis, by Technique, 2019 and 2030
Figure 59: Asia Pacific Multiplex Detection Immunoassays Market Attractiveness Analysis, by Technique, 2020–2030
Figure 60: Asia Pacific Multiplex Detection Immunoassays Market Value Share (%), by Application, 2019 and 2030
Figure 61: Asia Pacific Multiplex Detection Immunoassays Market Attractiveness Analysis, by Application, 2020–2030
Figure 62: Asia Pacific Multiplex Detection Immunoassays Market Value Share (%), by End-user, 2019 and 2030
Figure 63: Asia Pacific Multiplex Detection Immunoassays Market Attractiveness Analysis, by End-user, 2020–2030
Figure 64: Latin America Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 65: Latin America Multiplex Detection Immunoassays Market Value Share, by Country/Sub-region, 2019–2030
Figure 66: Latin America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Country/Sub-region, 2019–2030
Figure 67: Latin America Multiplex Detection Immunoassays Market Value Share Analysis, by Assay Type, 2019 and 2030
Figure 68: Latin America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Assay Type, 2020–2030
Figure 69: Latin America Multiplex Detection Immunoassays Market Value Share Analysis, by Technique, 2019 and 2030
Figure 70: Latin America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Technique, 2020–2030
Figure 71: Latin America Multiplex Detection Immunoassays Market Value Share (%), by Application, 2019 and 2030
Figure 72: Latin America Multiplex Detection Immunoassays Market Attractiveness Analysis, by Application, 2020–2030
Figure 73: Latin America Multiplex Detection Immunoassays Market Value Share (%), by End-user, 2019 and 2030
Figure 74: Latin America Multiplex Detection Immunoassays Market Attractiveness Analysis, by End-user, 2020–2030
Figure 75: Middle East & Africa Multiplex Detection Immunoassays Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 76: Middle East & Africa Multiplex Detection Immunoassays Market Value Share, by Country/Sub-region, 2019–2030
Figure 77: Middle East & Africa Multiplex Detection Immunoassays Market Attractiveness Analysis, by Country/Sub-region, 2019–2030
Figure 78: Middle East & Africa Multiplex Detection Immunoassays Market Value Share Analysis, by Assay Type, 2019 and 2030
Figure 79: Middle East & Africa Multiplex Detection Immunoassays Market Attractiveness Analysis, by Assay Type, 2020–2030
Figure 80: Middle East & Africa Multiplex Detection Immunoassays Market Value Share Analysis, by Technique, 2019 and 2030
Figure 81: Middle East & Africa Multiplex Detection Immunoassays Market Attractiveness Analysis, by Technique, 2020–2030
Figure 82: Middle East & Africa Multiplex Detection Immunoassays Market Value Share (%), by Application, 2019 and 2030
Figure 83: Middle East & Africa Multiplex Detection Immunoassays Market Attractiveness Analysis, by Application, 2020–2030
Figure 84: Middle East & Africa Multiplex Detection Immunoassays Market Value Share (%), by End-user, 2019 and 2030
Figure 85: Middle East & Africa Multiplex Detection Immunoassays Market Attractiveness Analysis, by End-user, 2020–2030
Figure 86: Global Multiplex Detection Immunoassays Market Share Analysis, by Company, 2019
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Multiplex Detection Immunoassays Market
